1. Home
  2. CRVS vs AROW Comparison

CRVS vs AROW Comparison

Compare CRVS & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • AROW
  • Stock Information
  • Founded
  • CRVS 2014
  • AROW 1851
  • Country
  • CRVS United States
  • AROW United States
  • Employees
  • CRVS N/A
  • AROW N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • AROW Major Banks
  • Sector
  • CRVS Health Care
  • AROW Finance
  • Exchange
  • CRVS Nasdaq
  • AROW Nasdaq
  • Market Cap
  • CRVS 459.0M
  • AROW 442.9M
  • IPO Year
  • CRVS 2016
  • AROW N/A
  • Fundamental
  • Price
  • CRVS $8.04
  • AROW $27.89
  • Analyst Decision
  • CRVS Strong Buy
  • AROW Hold
  • Analyst Count
  • CRVS 4
  • AROW 1
  • Target Price
  • CRVS $13.75
  • AROW $28.00
  • AVG Volume (30 Days)
  • CRVS 1.1M
  • AROW 33.4K
  • Earning Date
  • CRVS 11-04-2025
  • AROW 10-30-2025
  • Dividend Yield
  • CRVS N/A
  • AROW 4.16%
  • EPS Growth
  • CRVS N/A
  • AROW 5.41
  • EPS
  • CRVS N/A
  • AROW 2.07
  • Revenue
  • CRVS N/A
  • AROW $146,817,000.00
  • Revenue This Year
  • CRVS N/A
  • AROW $22.74
  • Revenue Next Year
  • CRVS N/A
  • AROW $6.91
  • P/E Ratio
  • CRVS N/A
  • AROW $13.50
  • Revenue Growth
  • CRVS N/A
  • AROW 7.84
  • 52 Week Low
  • CRVS $2.54
  • AROW $22.72
  • 52 Week High
  • CRVS $10.00
  • AROW $34.63
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 64.17
  • AROW 54.60
  • Support Level
  • CRVS $7.46
  • AROW $26.17
  • Resistance Level
  • CRVS $7.96
  • AROW $27.80
  • Average True Range (ATR)
  • CRVS 0.56
  • AROW 0.76
  • MACD
  • CRVS 0.01
  • AROW 0.13
  • Stochastic Oscillator
  • CRVS 75.46
  • AROW 83.90

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.

Share on Social Networks: